Top compounds associated with response to RFPL3S


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.11 0.05
mRNA QW-BI-011 CTRPv2 pan-cancer AAC 0.14 0.06
mRNA MI-2 CTRPv2 pan-cancer AAC 0.1 0.06
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.068 0.06
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.064 0.06
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.067 0.06
mRNA TAE684 CTRPv2 pan-cancer AAC 0.065 0.06
mRNA vorapaxar CTRPv2 pan-cancer AAC -0.07 0.06
mRNA SZ4TA2 CTRPv2 pan-cancer AAC 0.1 0.07
mRNA TGX221 CTRPv2 pan-cancer AAC -0.067 0.07
Download CSV